Early Gene Responses to Transforming Growth Factor-β in Cells Lacking Growth-Suppressive RB Function

References

• Andreasen, P. A., A. Riccio, K. G. Weldiner, R. Douglas, R. Sartorio, L. S. Nielsen, C. Oppenheimer, F. Blasi, and K. Danø. 1986. Plasminogen activator inhibitor type 1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. FEBS Lett. 209:213-218.
   PubMed Web of Science ®Google Scholar
• Andres, J. L., K. Stanley, S. Cheifetz, and J. Massagué. 1989. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β. J. Cell Biol. 109:3137-3145.
   PubMed Web of Science ®Google Scholar
• Ausubel, F., R. Brent, R. Kingston, D. Moore, J. Seidman, J. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York.
   Google Scholar
• Battegay, E. J., E. W. Raines, R. A. Seifert, D. F. Bowen-Pope, and R. Ross. 1990. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515-524.
   PubMed Web of Science ®Google Scholar
• Bentley, D. L., and M. Groudine. 1986. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (London) 321:702-706.
   PubMed Web of Science ®Google Scholar
• Bookstein, R., J. Y. Shew, P.-L. Chen, P. Scully, and W.-H. Lee. 1990. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712-715.
   PubMed Web of Science ®Google Scholar
• Boyd, F. T., and J. Massagué. 1989. Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kD membrane receptor. J. Biol. Chem. 264:2272-2278.
   PubMed Web of Science ®Google Scholar
• Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
   PubMed Web of Science ®Google Scholar
• Cesarman, E., R. Dalla-Favera, D. Bentley, and M. Groudine. 1987. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt Lymphoma. Science 238:1272-1275.
   PubMed Web of Science ®Google Scholar
• Chambard, J. C., and J. Pouyssegur. 1988. TGF-β inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events. J. Cell Physiol. 135:101-107.
   PubMedGoogle Scholar
• Cheifetz, S., J. L. Andres, and J. Massagué. 1988. The transforming growth factor-β receptor type III is a membrane proteoglycan. Domain structure of the receptor. J. Biol. Chem. 263:16984-16991.
   PubMed Web of Science ®Google Scholar
• Chen, P.-L., P. Scully, J.-Y. Shew, J. Y. J. Wang, and W.-H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198.
   PubMed Web of Science ®Google Scholar
• Coffey, R. J., Jr., C. C. Bascom, N. J. Sipes, R. Graves-Deal, B. E. Weissman, and H. L. Moses. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol. Cell. Biol. 8:3088-3093.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., and D. M. Livingston. Personal communication.
   Google Scholar
• DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
   PubMed Web of Science ®Google Scholar
• Dyson, N., K. Buchkovich, P. Whyte, and E. Harlow. 1989. The cellular 107 K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58:249-255.
   PubMedGoogle Scholar
• Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., J. W. Ludlow, E. Marsilio, J. A. DeCaprio, R. C. Millikan, S. H. Cheng, E. Paucha, and D. M. Livingston. 1989. An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110RB and a second cellular protein, p120. Cell 58:257-267.
   PubMedGoogle Scholar
• Fernandez-Pol, J. A., V. D. Talkad, D. J. Klos, and P. D. Hamilton. 1987. Suppression of the EGF-dependent induction of c-myc protooncogene expression by transforming growth factor β in a human breast carcinoma cell line. Biochem. Biophys. Res. Commun. 144:1197-1205.
   PubMedGoogle Scholar
• Fort, P., L. Marty, M. Piechaczyk, S. El Sabrouty, C. Dani, P. Jeanteur, and J. M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431-1442.
   PubMed Web of Science ®Google Scholar
• Furukawa, Y., J. A. DeCaprio, A. Freedman, Y. Kanakura, M. Nakamura, T. J. Ernst, D. M. Livingston, and J. D. Griffin. 1990. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA 87:2770-2774.
   PubMed Web of Science ®Google Scholar
• Grignani, F., L. Lombardi, D. Inghirami, L. Sternas, K. Cechova, and R. Dalla-Favera. 1990. Negative autoregulation of c-myc gene expression is inactivated in transformed cells. EMBO J. 9:3913-3922.
   PubMed Web of Science ®Google Scholar
• Howe, P. H., G. Draetta, and E. B. Leof. 1991. Transforming growth factor β1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol. Cell. Biol. 11:1185-1194.
   PubMed Web of Science ®Google Scholar
• Huang, H.-J., J.-K. Yee, J.-Y. Shew, P.-L. Chen, R. Bookstein, T. Friedmann, E. Y.-H. P. Lee, and W.-H. Lee. 1988. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563-1566.
   PubMed Web of Science ®Google Scholar
• Huang, S., N. P. Wang, B. Y. Tseng, W. H. Lee, and E. H. H. P. Lee. 1990. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J. 9:1815-1822.
   PubMed Web of Science ®Google Scholar
• Kim, S. J., H. Lee, P. D. Robbins, K. Busam, M. B. Sporn, and A. B. Roberts. 1991. Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc. Natl. Acad. Sci. USA 88:3052-3056.
   PubMed Web of Science ®Google Scholar
• Kimchi, A., X. F. Wang, R. A. Weinberg, S. Cheifetz, and J. Massagué. 1988. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 240:196-199.
   PubMed Web of Science ®Google Scholar
• Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massagué. 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185.
   PubMed Web of Science ®Google Scholar
• Laiho, M., L. Ronnstrand, J. Heino, J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massagué. 1991. Control of JunB and extracellular matrix protein expression by transforming growth factor-β1 is independent of simian virus 40 T antigen-sensitive growth-inhibitory events. Mol. Cell. Biol. 11:972-978.
   PubMedGoogle Scholar
• Laiho, M., F. M. B. Weis, F. T. Boyd, R. A. Ignotz, and J. Massagué. 1991. Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complemention between cells defective in TGF-β receptors I and II. J. Biol. Chem. 265:9108-9112.
   Google Scholar
• Laiho, M., F. M. B. Weis, and J. Massagué. 1990. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265:18518-18524.
   PubMed Web of Science ®Google Scholar
• Li, L., J.-S. Hu, and E. N. Olson. 1990. Different members of the jun proto-oncogene family exhibit distinct patterns of expression in response to type β transforming growth factor. J. Biol. Chem. 265:1556-1562.
   PubMed Web of Science ®Google Scholar
• Ludlow, J. W., J. A. DeCaprio, C.-M. Huang, W.-H. Lee, E. Paucha, and D. M. Livingston. 1989. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:57-65.
   PubMed Web of Science ®Google Scholar
• Ludlow, J. W., J. Shon, J. M. Pipas, D. M. Livingston, and J. A. DeCaprio. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation binding to and release from SV 40 large T-antigen. Cell 60:387-396.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1991. Tumor suppressor genes. Cell 64:313-326.
   PubMed Web of Science ®Google Scholar
• Massagué, J. 1987. Identification of receptors for type β transforming growth factor. Methods Enzymol. 146:174-195.
   PubMed Web of Science ®Google Scholar
• Massagué, J. 1990. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6:597-641.
   PubMedGoogle Scholar
• Massagué, J., F. T. Boyd, J. L. Andres, and S. Cheifetz. 1990. Mediators of TGF-β action: TGF-β receptors and TGF-β-binding proteoglycans. Ann. N.Y. Acad. Sci. 593:59-72.
   PubMedGoogle Scholar
• Missero, C., E. Filvaroff, and P. Dotto. 1991. Induction of transforming growth factor β1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins. Proc. Natl. Acad. Sci. USA 88:3489-3493.
   PubMedGoogle Scholar
• Moses, H. L., R. F. Tucker, E. B. Leof, R. J. J. Coffey, J. Halper, and G. D. Shipley. 1985. Type β transforming growth factor is a growth stimulator and growth inhibitor, p. 65-75. In J. Feramisco, B. Ozanne, and C. Stiles (ed.), Cancer cells, 3. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Nugent, M. A., and M. J. Newman. 1989. Inhibition of normal rat kidney cell growth by transforming growth factor-β is mediated by collagen. J. Biol. Chem. 264:18060-18067.
   PubMed Web of Science ®Google Scholar
• Penttinen, R. P., S. Kobayashi, and P. Bornstein. 1988. Transforming growth factor β increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc. Natl. Acad. Sci. USA 85:1105-1108.
   PubMed Web of Science ®Google Scholar
• Pertovaara, L., L. Sistonen, T. J. Bos, P. K. Vogt, J. Keski-Oja, and K. Alitalo. 1989. Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation. Mol. Cell. Biol. 9:1255-1262.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., J. T. Holt, R. W. Stein, and H. L. Moses. 1990. Transforming growth factor β-1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA 87:3758-3762.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, R. M. Pittelkow, K. Münger, P. M. Howley, and H. L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domains. Cell 61:777-785.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factor-betas, p. 419-472. In M. B. Sporn and A. B. Roberts (ed.), Peptide growth factors and their receptors. Springer-Verlag, Heidelberg.
   Google Scholar
• Rollins, B. J., and C. D. Stiles. 1989. Serum-inducible genes. Adv. Cancer Res. 53:1-32.
   PubMedGoogle Scholar
• Ryder, K., L. F. Lau, and D. Nathans. 1988. A gene activated by growth factors is related to v-jun. Proc. Natl. Acad. Sci. USA 85:1485-1491.
   Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Segarmi, P. R., and S. M. Seyedin. 1988. The high molecular weight receptor to transforming growth factor-β contains glycosaminoglycan chains. J. Biol. Chem. 263:8366-8370.
   PubMedGoogle Scholar
• Sorrentino, V., and S. Bandyopadhyay. 1989. TGFβ inhibits G0/S-phase transition in primary fibroblasts. Loss of response to the antigrowth effect of TGFβ is observed after immortalization. Oncogene 4:569-574.
   PubMedGoogle Scholar
• Takehara, K., E. C. LeRoy, and G. R. Grotendorst. 1987. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49:415-422.
   PubMed Web of Science ®Google Scholar
• Templeton, D. J., S. H. Park, L. Lanier, and R. A. Weinberg. 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033-3037.
   PubMed Web of Science ®Google Scholar
• Whyte, P., K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an antioncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (London) 334:124-129.
   PubMed Web of Science ®Google Scholar
• Wilding, G., G. Zugmeier, C. Knabbe, K. Flanders, and E. Gelmann. 1989. Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol. Cell. Endocrinol. 62:79-87.
   PubMedGoogle Scholar